Interim additional guidance for infection prevention and control recommendations for patients with suspected or confirmed COVID-19 in outpatient hemodialysis facilities
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Interim additional guidance for infection prevention and control recommendations for patients with suspected or confirmed COVID-19 in outpatient hemodialysis facilities
Filetype[PDF-59.26 KB]


Details:
  • Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
  • Description:
    These recommendations should be used with the CDC’s Interim Infection Prevention and Control Recommendations for Patients with Confirmed Coronavirus Disease 2019 (COVID-19) or Persons Under Investigation for COVID-19 in Healthcare Settings. This information is provided to clarify COVID-19 infection prevention and control (IPC) recommendations that are specific to outpatient hemodialysis facilities. This information complements, but does not replace, the general IPC recommendations for COVID-19. This guidance is based on the currently available information about COVID-19. This approach will be refined and updated as more information becomes available and as response needs change in the United States. It is important to stay informed about COVID-19 to prevent introduction and minimize spread of COVID-19 in your dialysis facility. Consult with public health authorities to understand if community transmission of COVID-19 is occurring in your community.
  • Content Notes:
    Background -- Recommendations.
  • Subject:
  • Document Type:
    Webpage
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Main Document Checksum:
  • File Type:
    1. Filetype[PDF - 109.54 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 7, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Updated March 7, 2020This interim guidance is for clinicians caring for patients with confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease (COVID-19).
      File Type:
      Filetype[PDF - 109.54 KB]
    2. Filetype[PDF - 109.54 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 7, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Updated March 7, 2020Recommendations in this document for actions by public health authorities apply primarily to US jurisdictions that are not experiencing sustained community transmission. CDC will provide separate guidance for US jurisdictions wit...
      File Type:
      Filetype[PDF - 109.54 KB]
    3. Filetype[PDF - 88.45 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 5, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This interim guidance is based on what is currently known about the Coronavirus Disease 2019 (COVID-19). The Centers for Disease Control and Prevention (CDC) will update this interim guidance as needed and as additional information becomes available.
      File Type:
      Filetype[PDF - 88.45 KB]
    4. Filetype[PDF - 79.60 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 8, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 79.60 KB]
    5. Filetype[PDF - 74.33 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 8, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 74.33 KB]
    6. Filetype[PDF - 99.92 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 8, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This interim guidance is based on what is currently known about coronavirus disease 2019 (COVID-19). The Centers for Disease Control and Prevention (CDC) will update this interim guidance as needed and as additional information becomes available.Pers...
      File Type:
      Filetype[PDF - 99.92 KB]
    7. Filetype[PDF - 496.18 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 10, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This page will be updated regularly at noon Mondays through Fridays. Numbers close out at 4 p.m. the day before reporting.CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak first started in Wuhan...
      File Type:
      Filetype[PDF - 496.18 KB]
    8. Filetype[PDF - 42.39 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 9, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This guidance is for Institutes of Higher Education with students participating in international travel or study abroad programs.Consider postponing or canceling student international travel programsGiven the global outbreak of novel coronavirus (COV...
      File Type:
      Filetype[PDF - 42.39 KB]
    9. Filetype[PDF - 171.65 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 10, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 171.65 KB]
    10. Filetype[PDF - 213.28 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 5, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Get your household ready for coronavirus disease 2019 : Interim guidance [Chinese]本临时指å—基于目å‰å·²èŽ·æ‚‰çš„冠状病毒疾病 2019 (COVID-19) æœ€æ–°ä¿¡æ¯ ç¾Žå›½ç–¾ç—…æŽ§åˆ¶å’Œé¢„é˜²ä¸­å¿ƒ (CDC) 将根æ®éœ€è¦ä»¥åŠèŽ·å¾—更多信æ¯æ—...
      File Type:
      Filetype[PDF - 213.28 KB]
    11. Filetype[PDF - 72.93 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      3 de marzo de 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Get your household ready for coronavirus disease 2019 : Interim guidance [Spanish]Esta guía interina se basa en lo que actualmente se sabe sobre la enfermedad del coronavirus 2019 (COVID-19). Los Centros para el Control y la Prevención de Enfermeda...
      File Type:
      Filetype[PDF - 72.93 KB]

You May Also Like:

  1. Filetype[PDF - 266.89 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    March 12, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Who this is for: Pediatric Healthcare ProvidersWhat this is for: To inform pediatric healthcare providers of information available on children with COVID-19.How to use: Refer to this information when managing pediatric patients with confirmed or susp...
    File Type:
    Filetype[PDF - 266.89 KB]
  2. Filetype[PDF - 110.53 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    April 14, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    File Type:
    Filetype[PDF - 110.53 KB]
  3. Filetype[PDF - 469.23 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    April 17 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    This page will be updated daily. Numbers close out at 4 p.m. the day before reporting.CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak first started in Wuhan, China, but cases have been identif...
    File Type:
    Filetype[PDF - 469.23 KB]
  4. Filetype[PDF - 101.44 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    April 16, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    The data on this page was collected earlier in the U.S. COVID-19 outbreak. Due to the ongoing community spread of the virus, this information is no longer relevant to understanding the current situation. This information was last updated on April 16,...
    File Type:
    Filetype[PDF - 101.44 KB]
  5. Filetype[PDF - 436.52 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    April 16 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated April 16, 2020This page will be updated regularly at noon Mondays through Fridays. Numbers close out at 4 p.m. the day before reporting.CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak ...
    File Type:
    Filetype[PDF - 436.52 KB]